Filing Details
- Accession Number:
- 0001209191-17-019697
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-09 18:03:10
- Reporting Period:
- 2017-03-07
- Filing Date:
- 2017-03-09
- Accepted Time:
- 2017-03-09 18:03:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1142596 | Nuvasive Inc | NUVA | Surgical & Medical Instruments & Apparatus (3841) | 330768598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1330401 | Jason Hannon | 7475 Lusk Blvd San Diego CA 92121 | President And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-03-07 | 97,375 | $34.82 | 142,336 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-03-07 | 72,535 | $74.63 | 69,801 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2017-03-08 | 24,340 | $74.21 | 45,461 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-03-08 | 500 | $74.80 | 44,961 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2017-03-07 | 97,375 | $0.00 | 97,375 | $34.82 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-01-02 | No | 4 | M | Direct |
Footnotes
- Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards.
- Payment of exercise price and tax liability by Issuer's withholding of shares incident to the respective option exercise.
- Sales effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1.
- Weighted average sales price from sales transactions ranging from $73.71 to $74.70. Upon request by the Commission staff or a security holderof the Issuer, either the Issuer or the Reporting Person will undertake to provide full information regarding the number of shares sold at eachseparate price.
- Weighted average sales price from sales transactions ranging from $74.74 to $74.91. Upon request by the Commission staff or a security holderof the Issuer, either the Issuer or the Reporting Person will undertake to provide full information regarding the number of shares sold at eachseparate price.
- The option, representing a right to purchase a total of 97,375 shares, was granted on January 2, 2009 and is fully vested.
Billionaire Hedge Funds
